Biogen Inc.

NasdaqGS:BIIB

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 19.16 B

Share Price

USD 130.67

Avg Daily Volume

1,490,409

Change (1 day)

2.29%

Change (1 year)

-35.97%

Change (YTD)

-14.55%

Biogen Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2025: 27.95%

Biogen Inc. EBITDA Margin is 27.95% for the Trailing 12 Months (TTM) ending June 30, 2025, a 20.20% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Biogen Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was 23.25%, a -24.57% change year over year.
Biogen Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was 30.83%, a 18.61% change year over year.
Biogen Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was 25.99%, a -8.77% change year over year.
Biogen Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was 28.49%, a -50.02% change year over year.